Absci is a biotechnology firm headquartered in Vancouver, Washington. Absci's mission is to unlock the potential of next-generation biologics with the creation of protein-based drugs, and engineered E. coli to produce proteins and antibodies.
Absci is hiring AI Scientists to develop and deploy state-of-the-art generative and predictive models for de novo antibody design, integrating computational work with wet-lab validation to accelerate therapeutic discovery.